These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26909316)

  • 21. Stimulation of mitochondrial oxidative capacity in white fat independent of UCP1: a key to lean phenotype.
    Flachs P; Rossmeisl M; Kuda O; Kopecky J
    Biochim Biophys Acta; 2013 May; 1831(5):986-1003. PubMed ID: 23454373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR-YY1-PGC1α pathway.
    Ji K; Zheng J; Lv J; Xu J; Ji X; Luo YB; Li W; Zhao Y; Yan C
    Free Radic Biol Med; 2015 Jul; 84():161-170. PubMed ID: 25843656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity.
    Samms RJ; Cheng CC; Kharitonenkov A; Gimeno RE; Adams AC
    Endocrinology; 2016 Apr; 157(4):1467-80. PubMed ID: 26901091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stress-induced FGF21 and GDF15 in obesity and obesity resistance.
    Keipert S; Ost M
    Trends Endocrinol Metab; 2021 Nov; 32(11):904-915. PubMed ID: 34526227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated stress response stimulates FGF21 expression: Systemic enhancer of longevity.
    Salminen A; Kaarniranta K; Kauppinen A
    Cell Signal; 2017 Dec; 40():10-21. PubMed ID: 28844867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FGF21-Mediated Improvements in Glucose Clearance Require Uncoupling Protein 1.
    Kwon MM; O'Dwyer SM; Baker RK; Covey SD; Kieffer TJ
    Cell Rep; 2015 Nov; 13(8):1521-7. PubMed ID: 26586424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
    Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
    Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
    Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
    Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.
    Nixon M; Stewart-Fitzgibbon R; Fu J; Akhmedov D; Rajendran K; Mendoza-Rodriguez MG; Rivera-Molina YA; Gibson M; Berglund ED; Justice NJ; Berdeaux R
    Mol Metab; 2016 Jan; 5(1):34-46. PubMed ID: 26844205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nutritional regulation of fibroblast growth factor 21: from macronutrients to bioactive dietary compounds.
    Pérez-Martí A; Sandoval V; Marrero PF; Haro D; Relat J
    Horm Mol Biol Clin Investig; 2016 Sep; 30(1):. PubMed ID: 27583468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
    Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
    Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue.
    Hondares E; Gallego-Escuredo JM; Flachs P; Frontini A; Cereijo R; Goday A; Perugini J; Kopecky P; Giralt M; Cinti S; Kopecky J; Villarroya F
    Metabolism; 2014 Mar; 63(3):312-7. PubMed ID: 24369918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FGF21-FGFR1 Coordinates Phospholipid Homeostasis, Lipid Droplet Function, and ER Stress in Obesity.
    Ye M; Lu W; Wang X; Wang C; Abbruzzese JL; Liang G; Li X; Luo Y
    Endocrinology; 2016 Dec; 157(12):4754-4769. PubMed ID: 27690692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity.
    Tsai S; Sitzmann JM; Dastidar SG; Rodriguez AA; Vu SL; McDonald CE; Academia EC; O'Leary MN; Ashe TD; La Spada AR; Kennedy BK
    J Clin Invest; 2015 Aug; 125(8):2952-64. PubMed ID: 26121750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1.
    Samms RJ; Smith DP; Cheng CC; Antonellis PP; Perfield JW; Kharitonenkov A; Gimeno RE; Adams AC
    Cell Rep; 2015 May; 11(7):991-9. PubMed ID: 25956583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose Tissues.
    Schlein C; Talukdar S; Heine M; Fischer AW; Krott LM; Nilsson SK; Brenner MB; Heeren J; Scheja L
    Cell Metab; 2016 Mar; 23(3):441-53. PubMed ID: 26853749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skeletal Muscle and Bone - Emerging Targets of Fibroblast Growth Factor-21.
    Sun H; Sherrier M; Li H
    Front Physiol; 2021; 12():625287. PubMed ID: 33762965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of energy balance by fibroblast growth factor 21.
    Cuevas-Ramos D; Aguilar-Salinas CA
    Horm Mol Biol Clin Investig; 2016 Jun; 30(1):. PubMed ID: 27318658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial proteostasis stress in muscle drives a long-range protective response to alleviate dietary obesity independently of ATF4.
    Guo Q; Xu Z; Zhou D; Fu T; Wang W; Sun W; Xiao L; Liu L; Ding C; Yin Y; Zhou Z; Sun Z; Zhu Y; Zhou W; Jia Y; Xue J; Chen Y; Chen XW; Piao HL; Lu B; Gan Z
    Sci Adv; 2022 Jul; 8(30):eabo0340. PubMed ID: 35895846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FGF21 as a mediator of adaptive responses to stress and metabolic benefits of anti-diabetic drugs.
    Kim KH; Lee MS
    J Endocrinol; 2015 Jul; 226(1):R1-16. PubMed ID: 26116622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.